Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15546092.
- Also identified by PMC identifier 7107896.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inhalation of nitric oxide (NO) improved arterial oxygenation and enabled the reduction of inspired oxygen therapy and airway pressure support in patients with severe acute respiratory syndrome (SARS). In addition, chest radiography showed decreased spread or density of lung infiltrates, and the physiological effects remained after termination of inhaled NO therapy. These findings suggest not only a pulmonary vasodilator effect of inhaled NO, but also an effect on SARS.
Medical subject headings
- Nitric Oxide
- Severe Acute Respiratory Syndrome